Dual-action therapies are emerging as a groundbreaking approach in the fight against concurrently HIV and cancer. These treatments focus on multiple pathways within disease mechanisms, offering {a{ promise of improved efficacy and reduced side effects compared to traditional monotherapy approaches. By integrating different therapeutic modalities, d